DICLOFENAC SODIUM | A077863 | UNIQUE PHARMACEUTICAL LABORATORIES A DIV OF JB CHEMICALS AND PHARMACEUTICALS LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Kratz & Barry LLP on behalf of Rubicon Research Private... FDA-2019-P-2407 · 5 docket documents Kratz & Barry LLP on behalf of Rubicon Research Private Limited filed this citizen petition pursuant to Section 505(j) requesting that the FDA designate Diclofenac Sodium delayed release tablet 75 mg held by Unique Pharmaceutical Laboratories as an additional reference standard for ANDA purposes, be | Other | 2019-05-17 | Open | Rubicon Research Private Limited |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.0660
per ea
Lowest NADAC/Unit
$0.0660
per ea
Brand NDCs
0
Generic NDCs
9
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16571020106DICLOFENAC SOD EC 75 MG TAB | $0.0660 | EA | Generic | — | 2026-06-17 |
| 16571020110DICLOFENAC SOD EC 75 MG TAB | $0.0660 | EA | Generic | — | 2026-06-17 |
| 16571020111DICLOFENAC SOD EC 75 MG TAB | $0.0660 | EA | Generic | — | 2026-06-17 |
| 16571020150DICLOFENAC SOD EC 75 MG TAB | $0.0660 | EA | Generic | — | 2026-06-17 |
| 68001028100DICLOFENAC SOD DR 75 MG TAB | $0.0660 | EA | Generic | — | 2026-06-17 |
| 68001028103DICLOFENAC SOD DR 75 MG TAB | $0.0660 | EA | Generic | — | 2026-06-17 |
Showing 6 of 9 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.